These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36198829)

  • 61. [Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].
    Arranz Martín A; Calle Pascual A; Del Cañizo Gómez FJ; González Albarrán O; Lisbona Gil A; Botella Serrano M; Pallardo Sánchez LF;
    Endocrinol Nutr; 2015 Apr; 62(4):171-9. PubMed ID: 25726367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Continuous Subcutaneous Insulin Infusions: Closing the Loop.
    Díaz-Balzac CA; Pillinger D; Wittlin SD
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1019-1033. PubMed ID: 36573281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
    Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial.
    Moreno-Fernandez J; Gómez FJ; Gálvez Moreno MÁ; Castaño JP
    J Diabetes Res; 2016; 2016():4171789. PubMed ID: 28004007
    [No Abstract]   [Full Text] [Related]  

  • 65. Glucose profiles of older adults with type 1 diabetes using sensor-augmented pump therapy in Australia: pre-randomisation results from the ORACL study.
    Trawley S; Ward GM; Vogrin S; Colman PG; Fourlanos S; Grills CA; Lee MH; MacIsaac RJ; Alipoor AM; O'Neal DN; O'Regan NA; Sundararajan V; McAuley SA
    Lancet Healthy Longev; 2022 Dec; 3(12):e839-e848. PubMed ID: 36410370
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Insulin pump therapy and continuous glucose monitoring].
    Schütz-Fuhrmann I; Rami-Merhar B; Fröhlich-Reiterer E; Hofer SE; Tauschmann M; Mader JK; Resl M; Kautzky-Willer A; Winhofer-Stöckl Y; Laimer M; Zlamal-Fortunat S; Weitgasser R
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):53-61. PubMed ID: 37101025
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Skin Patchable Sensor Surveillance for Continuous Glucose Monitoring.
    Manasa G; Mascarenhas RJ; Shetti NP; Malode SJ; Mishra A; Basu S; Aminabhavi TM
    ACS Appl Bio Mater; 2022 Mar; 5(3):945-970. PubMed ID: 35170319
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Continuous glucose monitoring for patients with diabetes: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2011; 11(4):1-29. PubMed ID: 23074416
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice.
    Phillip M; Nimri R; Bergenstal RM; Barnard-Kelly K; Danne T; Hovorka R; Kovatchev BP; Messer LH; Parkin CG; Ambler-Osborn L; Amiel SA; Bally L; Beck RW; Biester S; Biester T; Blanchette JE; Bosi E; Boughton CK; Breton MD; Brown SA; Buckingham BA; Cai A; Carlson AL; Castle JR; Choudhary P; Close KL; Cobelli C; Criego AB; Davis E; de Beaufort C; de Bock MI; DeSalvo DJ; DeVries JH; Dovc K; Doyle FJ; Ekhlaspour L; Shvalb NF; Forlenza GP; Gallen G; Garg SK; Gershenoff DC; Gonder-Frederick LA; Haidar A; Hartnell S; Heinemann L; Heller S; Hirsch IB; Hood KK; Isaacs D; Klonoff DC; Kordonouri O; Kowalski A; Laffel L; Lawton J; Lal RA; Leelarathna L; Maahs DM; Murphy HR; Nørgaard K; O'Neal D; Oser S; Oser T; Renard E; Riddell MC; Rodbard D; Russell SJ; Schatz DA; Shah VN; Sherr JL; Simonson GD; Wadwa RP; Ward C; Weinzimer SA; Wilmot EG; Battelino T
    Endocr Rev; 2023 Mar; 44(2):254-280. PubMed ID: 36066457
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.
    Rodbard D
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S3-S13. PubMed ID: 26784127
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Analysis of "Multicenter Evaluation Study Comparing a New Factory-Calibrated Real-Time Continuous Glucose Monitoring System to Existing Flash Glucose Monitoring System".
    Peyser T
    J Diabetes Sci Technol; 2023 Jan; 17(1):214-216. PubMed ID: 34651509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes: From Injections to Hybrid Closed-Loop Therapy.
    Davis GM; Peters AL; Bode BW; Carlson AL; Dumais B; Vienneau TE; Huyett LM; Ly TT
    Diabetes Care; 2023 Apr; 46(4):742-750. PubMed ID: 36787903
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Survey about do-it-yourself closed loop systems in the treatment of diabetes in Germany.
    Herzog AL; Busch J; Wanner C; von Jouanne-Diedrich HK
    PLoS One; 2020; 15(12):e0243465. PubMed ID: 33332410
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
    Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
    Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.
    Diedisheim M; Pecquet C; Julla JB; Carlier A; Potier L; Hartemann A; Jacqueminet S; Vidal-Trecan T; Gautier JF; Dubois Laforgue D; Fagherazzi G; Roussel R; Larger E; Sola-Gazagnes A; Riveline JP
    Diabetes Technol Ther; 2023 Apr; 25(4):279-286. PubMed ID: 36763338
    [No Abstract]   [Full Text] [Related]  

  • 77. Real-World Improvements in Hypoglycemia in an Insulin-Dependent Cohort With Diabetes Mellitus Pre/Post Tandem Basal-Iq Technology Remote Software Update.
    Pinsker JE; Leas S; Müller L; Habif S
    Endocr Pract; 2020 Jul; 26(7):714-721. PubMed ID: 33471639
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
    Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
    Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advanced Technology in the Management of Diabetes: Which Comes First-Continuous Glucose Monitor or Insulin Pump?
    Martin CT; Criego AB; Carlson AL; Bergenstal RM
    Curr Diab Rep; 2019 Jun; 19(8):50. PubMed ID: 31250124
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes.
    Kravarusic J; Aleppo G
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):37-55. PubMed ID: 31980120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.